2024年3月27日
A crucial step for start-ups on the road to success is ensuring that their innovations and trade secrets are adequately protected. In an increasingly competitive business world, confidentiality agreements and material transfer agreements (MTAs) have become indispensable tools. These legal agreements aim not only to transfer individual information and materials to third parties for specific purposes and to protect sensitive information, but also to clarify the rights and obligations between the parties involved.
Confidentiality agreements, also known as non-disclosure agreements (NDAs) or confidential disclosure agreements (CDAs) are agreements for the purpose of protecting sensitive information between parties. These agreements are of crucial importance for companies, especially start-ups, which often work with confidential data, trade secrets and innovative ideas. They set out the conditions under which information can be exchanged and oblige the parties to keep the information confidential and not to disclose it without the consent of the other party. This is particularly important when it comes to unpatented intellectual property. For start-ups, confidentiality agreements can play a key role in securing investments, partnerships and developing business strategies. Overall, confidentiality agreements are an indispensable tool for start-ups to protect their valuable resources and at the same time maintain their innovative strength.
Confidentiality agreements can, in principle, be drawn up freely by the parties in accordance with the principle of contractual freedom. However, these essential points should be considered:
Material transfer agreements (MTAs) are often concluded before the start of a close collaboration (e.g. as part of feasibility studies). MTAs exceed the scope of confidentiality agreements by providing provisions for the exchange of IP-protected material (such as cell lines) and related know-how between parties. The parties determine how the material may be used, whereby the party providing the material (the "Provider") may impose certain restrictions. MTAs also serve to protect the Provider’s potential liability, particularly if the material provided is infectious, hazardous or subject to special regulations. Generally, the Provider seeks to obtain rights to the research results arising from the use of the material. This can also be agreed between the parties through the MTAs.
When drafting material transfer agreements (MTAs), there are some important points to consider:
To Do / Recommendation: It is essential to conclude a confidentiality agreement before disclosing information to third parties. In addition to this, MTAs should also be concluded at an early stage of the collaboration in order to legally protect the transferred materials. We recommend using your own template and, if possible, avoiding working with a template provided by the other party. Before concluding such agreement, a legal review is recommended in any case to ensure that all legal aspects are adequately taken into account.
For more details, follow our webinar series "Life Sciences Start-Ups Coffee Break" and watch the webinar on Confidentiality Agreements and MTAs or contact us here.